Literature DB >> 22031629

Drug-induced subacute cutaneous lupus erythematosus related to doxycycline.

Kristen K Miller1, Julie Chu, Rishi Patel, Hideko Kamino.   

Abstract

An 84-year-old woman presented with a three-month history of scaly, erythematous, annular papules and plaques on her chest, back, arms, and legs, which developed after a short course of doxycycline. Histopathologic examination of skin biopsy specimens was consistent with subacute cutaneous lupus erythematosus (SCLE). A presumptive diagnosis of drug-induced SCLE secondary to doxycycline was made. Although minocycline-induced SCLE is widely reported in the literature, there are no known previous case reports of doxycycline-induced SCLE.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22031629

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  5 in total

1.  Doxycycline induced generalized bullous fixed drug eruption - A case report.

Authors:  Selvaraj Nitya; Kameswari Deepa; Adhimoolam Mangaiarkkarasi; Kaliaperumal Karthikeyan
Journal:  J Young Pharm       Date:  2013-12-25

Review 2.  Leveraging Heterogeneity in Systemic Lupus Erythematosus for New Therapies.

Authors:  Marilyn E Allen; Violeta Rus; Gregory L Szeto
Journal:  Trends Mol Med       Date:  2020-10-09       Impact factor: 11.951

3.  MMP-9/Gelatinase B Degrades Immune Complexes in Systemic Lupus Erythematosus.

Authors:  Estefania Ugarte-Berzal; Lise Boon; Erik Martens; Vasily Rybakin; Daniel Blockmans; Jennifer Vandooren; Paul Proost; Ghislain Opdenakker
Journal:  Front Immunol       Date:  2019-03-22       Impact factor: 7.561

4.  Doxycycline-Associated Dual Cutaneous Adverse Reaction to the Drug (CARD): Case Report of Concurrent Photosensitivity and Morbilliform Exanthem to Doxycycline.

Authors:  Joanne S Jacob; Philip R Cohen
Journal:  Cureus       Date:  2020-11-18

Review 5.  Tetracycline Allergy.

Authors:  Leslie A Hamilton; Anthony J Guarascio
Journal:  Pharmacy (Basel)       Date:  2019-08-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.